Literature DB >> 21235855

Coagulation factors V, VIII, and X, prothrombin time and activated partial thromboplastin time test results in thawed plasma stored at 1-6 ºC for 5 days.

Hossin Timori Naghadeh1, Mahtab Maghsudloo, Mohammad Reza Tabatabaei.   

Abstract

BACKGROUND: The aim of this study was to evaluate whether thawed plasma stored for 5 days at 1-6 ºC is appropriate for use.
MATERIALS AND METHODS: Samples taken from thawed plasma units stored for 5 days at 1-6 ºC were prepared for assays of the levels of factor V, factor VIII, and factor X, and for measurements of the activated partial thromboplastin time (aPTT) and prothrombin time (PT). The results obtained were then compared with those from other similar studies.
RESULTS: The average decreases in percentages of coagulation factors from day 1 to day 5 were 20% for factor V, 11% for factor X, and 25% for total factor VIII. The changes in the range of coagulation factors over the 5-day storage period were statistically significant, but the values remained within the haemostatic range. The average increases in the levels of PT and aPTT from day 1 to day 5 were also not clinically pathological.
CONCLUSIONS: Thawed fresh-frozen plasma stored for 5 days at 1-6 °C can be used in different cases of coagulopathy and can be used as an alternative to plasma frozen within 24 hours of phlebotomy.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21235855      PMCID: PMC3021403          DOI: 10.2450/2010.0032-10

Source DB:  PubMed          Journal:  Blood Transfus        ISSN: 1723-2007            Impact factor:   3.443


  8 in total

1.  Serial measurement of clotting factors in thawed plasma stored for 5 days.

Authors:  K A Downes; E Wilson; R Yomtovian; R Sarode
Journal:  Transfusion       Date:  2001-04       Impact factor: 3.157

2.  Coagulant stability and sterility of thawed S/D-treated plasma.

Authors:  Thomas P Nifong; Jan Light; Robert E Wenk
Journal:  Transfusion       Date:  2002-12       Impact factor: 3.157

3.  Study of coagulation factor activities in apheresed thawed fresh frozen plasma at 1-6 degrees C for five days.

Authors:  Rameshwar S Sidhu; Tuan Le; Brad Brimhall; Hannis Thompson
Journal:  J Clin Apher       Date:  2006-12       Impact factor: 2.821

4.  Stability of coagulation factors in thawed, solvent/detergent-treated plasma during storage at 4 degrees C for 6 days.

Authors:  C Buchta; M Felfernig; P Höcker; M Macher; G F Körmöczi; P Quehenberger; H Heinzl; P Knöbl
Journal:  Vox Sang       Date:  2004-10       Impact factor: 2.144

Review 5.  Replacement of massive blood loss.

Authors:  S Hiippala
Journal:  Vox Sang       Date:  1998       Impact factor: 2.144

6.  SD Plasma in TTP and coagulation factor deficiencies for which no concentrates are available.

Authors:  M S Horowitz; J C Pehta
Journal:  Vox Sang       Date:  1998       Impact factor: 2.144

7.  Coagulation parameters of thawed fresh-frozen plasma during storage at different temperatures.

Authors:  M Lamboo; D C W Poland; J C J Eikenboom; M S Harvey; E Groot; A Brand; R R P de Vries
Journal:  Transfus Med       Date:  2007-06       Impact factor: 2.019

8.  Coagulation factor levels in plasma frozen within 24 hours of phlebotomy over 5 days of storage at 1 to 6 degrees C.

Authors:  Mark H Yazer; Andrea Cortese-Hassett; Darrell J Triulzi
Journal:  Transfusion       Date:  2008-09-04       Impact factor: 3.157

  8 in total
  3 in total

1.  Coagulation Factor Activities Changes Over 5 Days in Thawed Fresh Frozen Plasma Stored at Different Initial Storage Temperatures.

Authors:  Siti Salmah Noordin; Faraizah Abdul Karim; Wan Mohd Zahiruddin Bin Wan Mohammad; Abdul Rahim Hussein
Journal:  Indian J Hematol Blood Transfus       Date:  2017-10-07       Impact factor: 0.900

Review 2.  10 Years of Experience with the First Thawed Plasma Bank in Germany.

Authors:  Kathleen Selleng; Andreas Greinacher
Journal:  Transfus Med Hemother       Date:  2021-10-08       Impact factor: 3.747

3.  Construction of a rabbit model with vinorelbine administration via peripherally inserted central catheter and dynamic monitoring of changes in phlebitis and thrombosis.

Authors:  Liquan Huang; Guiyuan Chen; Qinghua Hu; Bo Hu; Louying Zhu; Luyan Fang
Journal:  Exp Ther Med       Date:  2022-01-11       Impact factor: 2.447

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.